Lista de obras -

Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology

artículo científico publicado en 2018

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

artículo científico publicado en 2011

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

artículo científico publicado en 2014

Bone Marrow Expression of Mast Cell Disorders

artículo científico publicado en 2018

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

artículo científico

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

artículo científico publicado en 2013

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

artículo científico publicado en 2018

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

artículo científico publicado en 2011

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

artículo científico publicado en 2010

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

artículo científico publicado en 2015

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

artículo científico publicado en 2016

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

scientific article published on 01 September 2012

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

artículo científico publicado en 2019

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

scientific article published on 17 May 2018

Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

artículo científico

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

artículo científico

Dermoscopic features of skin lesions in patients with mastocytosis

artículo científico publicado en 2011

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

artículo científico publicado en 2015

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

artículo científico publicado en 2015

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

artículo científico publicado el 10 de noviembre de 2010

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

artículo científico publicado en 2011

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

artículo científico

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

artículo científico publicado en 2019

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

artículo científico publicado en 2009

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

artículo científico publicado en 2012

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

artículo científico publicado en 2015

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

artículo científico publicado en 2015

Kounis syndrome following the performance of skin test to amoxicillin

artículo científico publicado en 2014

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

artículo científico publicado en 2015

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

artículo científico publicado en 2011

Mast cell-related disorders presenting with Kounis syndrome

artículo científico publicado en 2012

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

artículo científico publicado en 2022

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

artículo científico publicado en 2013

Perioperative anaphylaxis in a patient with a solitary mastocytoma

artículo científico publicado en 2019

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

artículo científico publicado en 2015

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

artículo científico publicado en 2013

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

artículo científico publicado en 2013

Simultaneous occurrence of cutaneous mastocytosis and juvenile xanthogranuloma in a child: Random or true association?

scientific article published on 05 May 2020

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

artículo científico publicado en 2012

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

artículo científico publicado en 2015

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

artículo científico publicado en 2016

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

artículo científico publicado en 2014

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.

artículo científico publicado en 2013

Lista de obras de

Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology

An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.

Anaphylaxis as a clinical manifestation of clonal mast cell disorders.

Bone Marrow Expression of Mast Cell Disorders

Bone Marrow Mast Cell Antibody-Targetable Cell Surface Protein Expression Profiles in Systemic Mastocytosis ⬇️

CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis

Characterization of CD34+ hematopoietic cells in systemic mastocytosis: potential role in disease dissemination.

Clinical impact of pregnancy in mastocytosis: a study of the Spanish Network on Mastocytosis (REMA) in 45 cases

Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms.

Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.

Complete response to gemtuzumab ozogamicin in a patient with refractory mast cell leukemia.

Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions

Cutaneous Mastocytosis With Predominant Infiltration of Promastocytes

Cutaneous Mastocytosis in Adults and Children: New Classification and Prognostic Factors

Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?

Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology

Dermoscopic features of skin lesions in patients with mastocytosis

Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications

Diagnosis and classification of mastocytosis in non-specialized versus reference centres: a Spanish Network on Mastocytosis (REMA) study on 122 patients.

Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis ⬇️

Evaluation of the WHO criteria for the classification of patients with mastocytosis.

Flow cytometry in mastocytosis: utility as a diagnostic and prognostic tool

Frequency and prognostic impact of KIT and other genetic variants in indolent systemic mastocytosis

IgE-mediated anaphylaxis to Hippobosca equina in a patient with systemic mastocytosis.

Immunophenotyping in systemic mastocytosis diagnosis: 'CD25 positive' alone is more informative than the 'CD25 and/or CD2' WHO criterion.

Increased IL6 plasma levels in indolent systemic mastocytosis patients are associated with high risk of disease progression

KIT D816V-mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression.

Kounis syndrome following the performance of skin test to amoxicillin

Management of Anesthesia in Adult and Pediatric Mastocytosis: A Study of the Spanish Network on Mastocytosis (REMA) Based on 726 Anesthetic Procedures.

Mast cell activation disorders presenting with cerebral vasospasm-related symptoms: a "Kounis-like" syndrome?

Mast cell-related disorders presenting with Kounis syndrome

Mastocytosis presenting with mast cell-mediator release-associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features

Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM.

Perioperative anaphylaxis in a patient with a solitary mastocytoma

Response to celecoxib in a patient with indolent systemic mastocytosis presenting with intractable diarrhea

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome

Short-term omalizumab treatment in an adolescent with cutaneous mastocytosis.

Simultaneous occurrence of cutaneous mastocytosis and juvenile xanthogranuloma in a child: Random or true association?

Systemic mastocytosis as a risk factor for severe Hymenoptera sting-induced anaphylaxis.

Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: A report of two cases

Systemic mastocytosis presenting as occupational IgE-mediated anaphylaxis to pine processionary caterpillar.

The immunophenotype of mast cells and its utility in the diagnostic work-up of systemic mastocytosis

Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations.